Online citations, reference lists, and bibliographies.
← Back to Search

Fabrication, Characterization And Cytotoxicity Studies Of Ionically Cross-linked Docetaxel Loaded Chitosan Nanoparticles.

Ankit Jain, Kanika Thakur, G. Sharma, P. Kush, U. K. Jain
Published 2016 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The present investigation aimed at the fabrication and characterization of ionically cross-linked docetaxel (DTX) loaded chitosan nanoparticles (DTX-CH-NP) using ionic gelation technique with sodium tripolyphosphate (TPP) as the cross-linking agent. The formulated nanoparticles were characterized in terms of particle size, drug entrapment efficiency (EE), scanning electron microscopy (SEM), in vitro release and cytotoxicity studies. Formulation factors (chitosan, TPP and drug concentration) were examined systematically for their effects on size of the nanoparticles. The average size of the nanoparticles was observed to be in the range of 159.2 ± 3.31 to 220.7 ± 2.23 nm with 78-92% encapsulation efficiency (EE). The in vitro cytotoxicity studies on breast cancer cell lines (MDA-MB-231) revealed the advantages of DTX-CH-NP over pure DTX with approximately 85% cell viability reduction. The results indicate that systematic modulation of the surface charge and particle size of ionically cross-linked nanoparticles can be readily achieved with the right control of critical processing parameters. Thus, DTX-CH-NP presents a promising delivery alternative for breast cancer treatment.
This paper references
10.2147/IJN.S46921
How nanotechnology can enhance docetaxel therapy
L. Zhang (2013)
10.1016/S0939-6411(03)00161-9
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.
J. Berger (2004)
10.1016/j.ijpharm.2012.04.008
Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Q. Liu (2012)
10.1016/j.jconrel.2012.12.013
Biocompatibility of engineered nanoparticles for drug delivery.
S. Naahidi (2013)
10.2147/IJN.S56932
Polymeric nanoparticles for targeted treatment in oncology: current insights
R. Prabhu (2015)
10.2165/00003495-200565170-00007
Docetaxel: a review of its use in metastatic breast cancer.
K. Lyseng-Williamson (2005)
10.1038/nnano.2007.387
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
10.1016/J.COLSURFB.2007.04.009
Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Quan Gan (2007)
10.3109/10717544.2013.879964
Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles
Shougang Jiang (2015)
10.1016/J.CARBPOL.2007.06.015
Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle
Min Lang Tsai (2008)
10.1016/S0168-3659(02)00212-2
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
Cristina Fonseca (2002)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.1016/J.CARBPOL.2008.08.019
Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study
Wan Ajun (2009)
10.1016/j.carbpol.2012.03.010
Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios.
Susana Rodrigues (2012)
10.1016/J.CARBPOL.2010.04.040
The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer
Min Lang Tsai (2011)
10.1016/S0032-3861(03)00620-7
Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads
F. L. Mi (2003)
10.1016/J.COLSURFB.2005.06.001
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Quan Gan (2005)
10.1080/10611860701794353
Polymeric nanoparticles for cancer therapy
S. Parveen (2008)
Chitin and chitosan: Chemistry, properties and applications
P. Dutta (2004)
10.1016/J.CARBPOL.2008.08.008
Characterization and evaluation of hydrophobically modified chitosan scaffolds: Towards design of enzyme immobilized flow-through electrodes
M. Cooney (2009)
10.1016/j.addr.2013.11.009
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
N. Bertrand (2014)
10.1016/j.jpba.2009.01.016
PK and tissue distribution of docetaxel in rabbits after i.v. administration of liposomal and injectable formulations.
L. Zhao (2009)
10.1002/JPS.2600521210
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.
T. Higuchi (1963)
10.1016/S0378-5173(02)00487-8
Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
J. A. Ko (2002)
10.1016/j.jconrel.2008.02.003
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
H. Hwang (2008)
10.1016/S0928-0987(01)00095-1
Modeling and comparison of dissolution profiles.
P. Costa (2001)
10.1016/j.colsurfb.2013.09.010
Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
J. Dou (2014)
10.3109/1061186X.2012.712130
Nanoparticles-mediated drug delivery approaches for cancer targeting: a review
S. Sultana (2013)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1016/S0168-3659(97)00252-6
DNA-polycation nanospheres as non-viral gene delivery vehicles.
K. Leong (1998)
10.1097/00001813-199506000-00001
Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience.
M. Bissery (1995)
10.1016/J.IJPHARM.2005.01.042
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
Yan Wu (2005)
10.1111/jphp.12472
Preparation and evaluation of lipid emulsified docetaxel‐loaded nanoparticles
F. Zhang (2015)
10.1093/JN/134.4.945
Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice.
Yasunori Maeda (2004)
10.2147/IJN.S26365
Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
H. Hosseinzadeh (2012)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1016/J.COSSMS.2013.01.002
Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles
Jun Pil Jee (2012)
10.1016/J.CARBPOL.2004.04.002
Spray-drying of solutions containing chitosan together with polyuronans and characterisation of the microspheres
C. Muzzarelli (2004)
10.1093/JNCI/83.4.288
Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol.
I. Ringel (1991)
10.1186/1556-276X-6-260
Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies
V. Sanna (2011)
10.1007/s11095-010-0180-0
Evaluation of Docetaxel-Loaded Intravenous Lipid Emulsion: Pharmacokinetics, Tissue Distribution, Antitumor Activity, Safety and Toxicity
M. Zhao (2010)
10.1186/1556-276X-6-354
Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models
H. Song (2011)
10.1016/S0169-409X(01)00112-0
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).
J. Siepmann. (2001)
10.1016/J.PROGPOLYMSCI.2011.02.001
Chitosan—A versatile semi-synthetic polymer in biomedical applications
M. Dash (2011)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1016/j.biomaterials.2014.03.017
Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Z. Yang (2014)
10.1016/j.jconrel.2012.03.017
Chitosan-based drug nanocarriers: where do we stand?
M. Garcia-Fuentes (2012)
10.1016/j.addr.2012.09.028
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).
J. Siepmann (2001)
10.1002/anie.201503863
Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics.
J. Wu (2015)
10.1016/j.ejps.2010.12.007
Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Abdallah Makhlof (2011)
10.1016/S0141-8130(98)00036-1
Effect of temperature on the intrinsic viscosity and conformation of chitosans in dilute HCl solution.
R. H. Chen (1998)
10.1016/j.actbio.2013.06.034
Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Wei Tao (2013)



This paper is referenced by
Synthesis of N,O-Carboxymethyated chitosan and its application in the development of acyclovir loaded nanoparticles.
S. Adnan (2019)
10.1016/j.procbio.2020.08.007
Immobilization and characterization of horseradish peroxidase into chitosan and chitosan/PEG nanoparticles: A comparative study
Micael Nunes Melo (2020)
10.1016/J.JDDST.2018.11.024
A novel tanshinone IIA/chitosan solid dispersion: Preparation, characterization and cytotoxicity evaluation
C. Luo (2019)
10.3390/md14100174
Novel Spray Dried Glycerol 2-Phosphate Cross-Linked Chitosan Microparticulate Vaginal Delivery System—Development, Characterization and Cytotoxicity Studies
E. Szymańska (2016)
10.3762/bjnano.7.178
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
H. Zhang (2016)
10.3109/10717544.2016.1155244
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation
G. Sharma (2016)
10.1016/J.JDDST.2018.05.029
Design of alpha mangostin-loaded chitosan/alginate controlled-release nanoparticles using genipin as crosslinker
W. Samprasit (2018)
10.1590/S2175-97902017000400242
Investigation of the parameters affecting the release of flurbiprofen from chitosan microspheres
Müşerref Günseli Yüksel Tilkan (2018)
10.1016/j.bioactmat.2020.08.019
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
Ye Liang (2021)
10.1002/aoc.5663
Synthesis of pyrazolopyrimidines in mild conditions by gold nanoparticles supported on magnetic ionic gelation in aqueous solution
Lanlan Yu (2020)
10.2147/DDDT.S122984
Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting
Jin-Seok Choi (2017)
10.1016/j.colsurfb.2016.09.020
Tumor targeting strategies for chitosan-based nanoparticles.
Xingzhen Zhang (2016)
10.2147/IJN.S220410
Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus
Tahereh Zadeh Mehrizi (2019)
10.1080/21691401.2018.1557672
Biocompatible disulphide cross-linked sodium alginate derivative nanoparticles for oral colon-targeted drug delivery
Asila Dinie Ayub (2019)
10.1186/s12938-019-0624-7
Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation
N. Qu (2019)
10.1016/j.msec.2016.09.080
Poly(lactic acid) nanoparticles loaded with ursolic acid: Characterization and in vitro evaluation of radical scavenging activity and cytotoxicity.
E. Antônio (2017)
10.1080/03639045.2017.1318895
Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells
J. Jiang (2017)
10.1021/acs.jafc.7b04451
Improved Chemical Stability and Antiproliferative Activities of Curcumin-Loaded Nanoparticles with a Chitosan Chlorogenic Acid Conjugate.
Y. Fan (2017)
10.2147/IJN.S203113
Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer
W. Zhang (2019)
10.1007/s13346-020-00795-4
Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity
Md. Meraj Anjum (2020)
10.2174/1871525718666200203112502
Design and Development of Lomustine Loaded Chitosan Nanoparticles for Efficient Brain Targeting.
Anupriya Anand (2020)
10.1016/J.JDDST.2019.01.027
Preparation, characterization and stability evaluation of ionic liquid blended chitosan tripolyphosphate microparticles
R. Safdar (2019)
10.3390/ph12010032
Development and Characterization of Chitosan Microparticles-in-Films for Buccal Delivery of Bioactive Peptides
P. Batista (2019)
10.1039/C9RA02680K
Fixing CO2 into β-oxopropylcarbamates in neat condition by ionic gelation/Ag(I) supported on dendritic fibrous nanosilica
L. Chang (2019)
10.1038/s41598-018-30103-7
Novel Nanosized Chitosan-Betulinic Acid Against Resistant Leishmania Major and First Clinical Observation of such parasite in Kidney
Tahereh Zadeh Mehrizi (2018)
10.1016/j.ijpharm.2020.119038
Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: optimization using Box-Behnken design, stability and in vivo study.
Wisam Khalaf Delan (2020)
10.1002/CPLU.201600363
Multifunctional Mixed Micelles for Efficient Docetaxol Delivery for Cancer Therapy.
P. Zhang (2016)
10.1016/j.carbpol.2018.07.072
Enhancing antibiofilm activity with functional chitosan nanoparticles targeting biofilm cells and biofilm matrix.
Yulong Tan (2018)
10.1080/10717544.2017.1373163
Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel
T. Ramasamy (2017)
10.3390/md15040096
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy
A. Babu (2017)
10.14302/ISSN.2690-4829.JEN-18-2043
Chitin and Chitinases: Biomedical and Environmental Applications of Chitin and Its Derivatives
P. Rameshthangam (2020)
10.1016/B978-0-08-100741-9.00002-4
Preparative methods and devices of bioinspired materials in drug-delivery systems
S. Gorgieva (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar